Patent Term Extension Application for AeroPace® System, Patent No. 10,765,867 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2025-E-1226

Patent Term Extension Application for AeroPace® System, Patent No. 10,765,867

Documents

Comments

Description

Open

Comment Period OpensMay 14, 2025

Comment Period ClosesApr 28, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; AEROPACE FR Doc: 2026-03849	Feb 26, 2026	--

CDER

Patent Term Extension Application

Patent No. 10,765,867

AeroPace® System

Lungpacer Medical, Inc.

Bookoff McAndrews, PLLC

Open